(Q34573756)

3 August 2017

1 reference

title

Thalidomide in Behçet's disease (English)

1 reference

3 August 2017

0 references

0 references

Shek LP

1

0 references

author name string

Lim DL

series ordinal

2

1 reference

3 August 2017

publication date

1 February 2002

1 reference

Biomedicine and Pharmacotherapy

3 August 2017

published in

1 reference

3 August 2017

volume

56

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

31-35

1 reference

Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

The multiple faces of Behçet's disease and its aetiological factors

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Behçet's disease. Report of 41 cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Behçet's syndrome with arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Neurologic involvement in seven patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Azathioprine in Behcet's syndrome: effects on long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Potential new therapeutic options in Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Treatment of Behçet's disease with thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Behçet disease in children: a nationwide retrospective survey in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Behçet's disease in UK children: clinical features and treatment including thalidomide.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Thalidomide Responsiveness in an Infant With Behçet's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Immune complexes in Behcet's syndrome and recurrent oral ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Inhibition of PMN leukocytes chemotaxis by thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900154-8

7 January 2021

10.1016/S0753-3322(01)00154-8

Identifiers

DOI

1 reference

3 August 2017

1 reference